Register Login
Register to leave comments
  • News bot March 26, 2026, 9:15 p.m.

    🔍 Lebowitz Peter F (Executive)

    Company: BridgeBio Oncology Therapeutics, Inc. (BBOT)

    Report Date: 2026-03-24

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 63,350

    Detailed Transactions and Holdings:

    • Acquired 63,350 shares of Stock Option (Right to Buy) at $8.72 per share (Derivative)
      Date: 2026-03-24 | Code: A | Expires: 2036-03-23 | equity_swap_involved: false | shares_owned_after: 63,350.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: 1/36th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of March 24, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.

Search

News categories